Latest Conference

Milena McLaughlin, PharmD, MSc, explains the different ways that antimicrobial shortages can impact patient care.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains which studies are ideal to run through a meta-analysis.

Lauri A. Hicks, DO, discusses the use of immunotherapy in tackling antibiotic resistance.

Nicola Thompson, PhD, shares what is needed to estimate the burden of healthcare-associated infections in nursing homes.

Snigdha Vallabhaneni, MD, MPH, discusses the keys to controlling the spread of Candida auris.

Lillian Abbo, MD, shares key elements that clinicians should incorporate into antimicrobial stewardship practices.

Jeremy Burrows, DPhil, MA, explains how new antimalarials could change the game for countries where malaria is endemic.

Gonzalo Bearman, MD, MPH, shares a few things to keep in mind when using bundled approaches against C. difficile.

Arjun Srinivasan, MD, explains where outbreaks are most likely to occur within healthcare facilities.

Elizabeth Phillips, MD, FRCPC, FRACP, explains the current preferred methods for drug skin testing and desensitization.

Kenneth Mayer, MD, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.

Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.

Davey Legendre, PharmD, MBA, BCPS, sheds light on the prevalence of confirmed beta-lactam allergies in patients.

Benjamin Young, MD, PhD, shares how many catalysts for the HIV epidemic exist within cities.

Arjun Srinivasan, MD, explains the risk of surgeries resulting in outbreaks.

Genovefa Papanicolaou, MD, explains in which patient population is CMV most harmful.

Arjun Srinivasan, MD, explains how healthcare officials can keep the patient at the center of outbreak investigations.

Gonzalo Bearman, MD, MPH, explains when to prescribe antibiotics and suggests to pay attention to the data when it comes to length of treatment.

The impact of viruses on community-acquired pneumonia seems to be greater than initially realized and the use of procalcitonin may help distinguish infection type for appropriate treatment.

Snigdha Vallabhaneni, MD, MPH, discusses candidemia mortality rates in low- and middle-income versus developed countries.

Contagion® sat down with Rodrigo Mendes, PhD, to discuss research exploring evolving resistance among antibiotics to treat skin infections.

Kirk Hevener, PharmD, PhD, explains the drawbacks of first-line drugs that are currently used to treat C. difficile infections.

The weekly Business Watch includes the latest industry news that practitioners working in infectious diseases need to know.

Genovefa Papanicolaou, MD, provides a brief overview of cytomegalovirus.

Conan MacDougall, PharmD, MAS, BCPS-AQ ID, sheds light on behavior change interventions that could positively affect antibiotic prescribing practices.

Thomas File, MD, MSc explains what pleuromutilin antibiotics are and how they work.

Julian Hurdle, PhD explains why some patients experience recurrence of Clostridium difficile after treatment.

Alan Gross, PharmD, BCPS-AQID, explains how antimicrobial stewardship programs need to be strengthened in long-term care facilities.